Esber Henry Jemil
SEC-identified person · CIK 1391501 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| North Horizon, Inc. NORHD | Director | filed 2012 - 2019 |
| Nanomix Corp NO SYMBOL | Director | filed 2014 - 2015 |
| Seelos Therapeutics, INC. SEEL | Director · EVP Pre-Clinical Business Dev. | filed 2009 - 2012 |
| PRO Pharmaceuticals INC prw | Director | filed 2007 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.